Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Dow
Johnson and Johnson
Colorcon
Baxter

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

CHLOROTHIAZIDE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Chlorothiazide patents expire, and when can generic versions of Chlorothiazide launch?

Chlorothiazide is a drug marketed by Abc Holding, Hikma Intl Pharms, Lederle, Mylan, Sandoz, Watson Labs, Hikma Pharms, Am Regent, Fresenius Kabi Usa, Mylan Institutional, Sagent Pharms Inc, and Sun Pharm. and is included in twenty-three NDAs.

The generic ingredient in CHLOROTHIAZIDE is chlorothiazide sodium. There are forty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the chlorothiazide sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Chlorothiazide

A generic version of CHLOROTHIAZIDE was launched as chlorothiazide sodium by FRESENIUS KABI USA on December 14th, 2019.

Drug patent expirations by year for CHLOROTHIAZIDE
Drug Prices for CHLOROTHIAZIDE

See drug prices for CHLOROTHIAZIDE

Recent Clinical Trials for CHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of VirginiaPhase 4
Vanderbilt UniversityPhase 4
Yale UniversityN/A

See all CHLOROTHIAZIDE clinical trials

Pharmacology for CHLOROTHIAZIDE
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for CHLOROTHIAZIDE
Synonyms for CHLOROTHIAZIDE
102632-EP2270011A1
102632-EP2272841A1
102632-EP2277879A1
102632-EP2298776A1
102632-EP2301936A1
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide,6-chloro-, 1,1-dioxide
2H-1,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide
58-94-6
6-chloro-1,1-dioxo-2H-1?^{6},2,4-benzothiadiazine-7-sulfonamide
6-chloro-1,1-dioxo-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6-chloro-1,1-dioxo-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide
6-chloro-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
6-chloro-1,1-dioxo-4H-1$l;{6},2,4-benzothiadiazine-7-sulfonamide
6-Chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-2H-1,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-chloro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide
6-chloro-4H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-chloro-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide
6-Chloro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
6-Chloro-7-sulfamoyl-2H-1,4-benzothiadiazine 1,1-dioxide
77W477J15H
AB00051940_05
AB00051940_06
AB00051940-04
AB0010688
AB2000186
AC-18732
AC1L1EBB
ACM1189440796
AKOS015896601
AKOS024319450
Aldoclor
Aldoclor (Salt/Mix)
Alurene
AN-10251
AS-11760
BCP24474
BDBM39351
BIDD:GT0635
BPBio1_000070
BRD-K88682005-001-05-9
BRD-K88682005-001-07-5
BSPBio_000062
BSPBio_002003
C 4911
C07461
C7H6ClN3O4S2
CAS-58-94-6
CCG-38953
CCRIS 5999
CHEBI:3640
CHEMBL3392493
CHEMBL842
Chloriazid
Chlorosal
Chlorothiazid
Chlorothiazide (JAN/USP/INN)
Chlorothiazide [USAN:INN:BAN]
Chlorothiazide [USP:INN:BAN]
Chlorothiazide, 98%
Chlorothiazide, European Pharmacopoeia (EP) Reference Standard
Chlorothiazide, Pharmaceutical Secondary Standard; Certified Reference Material
Chlorothiazide, thiazide diuretic
Chlorothiazide, United States Pharmacopeia (USP) Reference Standard
Chlorothiazidum
Chlorothiazidum [INN-Latin]
Chlorthiazid
Chlorthiazide
Chlorthiazidum
Chlortiazid
Chlorurit
Chlotride
Chlrosal
cid_2720
Clorotiazida
Clorotiazida [INN-Spanish]
Clorotiazide
Clorotiazide [DCIT]
Clotride
component of Aldoclor
CPD000058429
CS-2171
CTK8F8613
D00519
DB00880
Diupres (Salt/Mix)
Diuresal
Diuril
Diuril (TN)
Diuril Boluses
Diuril Boluses, Veterinary
Diuril;Chlotride
Diurilix
Diurite
Diutrid
DivK1c_000675
DSSTox_CID_2800
DSSTox_GSID_22800
DSSTox_RID_76733
DTXSID0022800
EINECS 200-404-9
EU-0100254
Flumen
FT-0602975
GTPL4835
HMS1568D04
HMS1920K15
HMS2091C18
HMS2095D04
HMS2232N22
HMS3259K15
HMS3260D10
HMS3370A15
HMS3655M13
HMS3712D04
HMS502B17
HSDB 3030
HY-B0224
I06-2278
IDI1_000675
JBMKAUGHUNFTOL-UHFFFAOYSA-N
KBio1_000675
KBio2_000594
KBio2_003162
KBio2_005730
KBio3_001223
KBioGR_000780
KBioSS_000594
KS-00001F6W
Lopac-C-4911
Lopac0_000254
LP00254
LS-244
MCULE-3497410863
Mechlozid
MFCD00058576
Minzil
MLS000028398
MolPort-003-666-143
MolPort-003-845-912
NC00500
NCGC00015242-01
NCGC00015242-02
NCGC00015242-03
NCGC00015242-04
NCGC00015242-05
NCGC00015242-06
NCGC00015242-07
NCGC00015242-08
NCGC00015242-09
NCGC00015242-10
NCGC00015242-12
NCGC00015242-13
NCGC00091042-01
NCGC00091042-02
NCGC00091042-03
NCGC00091042-04
NCGC00091042-05
NCGC00258525-01
NCGC00260939-01
Neo-Dema
NINDS_000675
NSC 25693
NSC-25693
NSC-756682
NSC25693
NSC756682
Pharmakon1600-01500180
Prestwick_56
Prestwick0_000251
Prestwick1_000251
Prestwick2_000251
Prestwick3_000251
s1641
Salisan
Salunil
Saluretil
Saluric
SAM002554891
SBI-0050242.P004
SC-45427
SCHEMBL22329
Sk-chlorothiazide
SMR000058429
SPBio_000288
SPBio_002281
Spectrum_000134
SPECTRUM1500180
Spectrum2_000154
Spectrum3_000342
Spectrum4_000280
Spectrum5_001446
SR-01000075604
SR-01000075604-1
SR-01000075604-3
SR-01000075604-5
SW219268-1
Thiazide
Tox21_110107
Tox21_110107_1
Tox21_200972
Tox21_500254
UNII-77W477J15H
Urinex
W-105353
Warduzide
WLN: T66 BSWM ENJ HG ISZW
Yadalan
Z1691545266
ZINC3872055

US Patents and Regulatory Information for CHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abc Holding CHLOROTHIAZIDE chlorothiazide TABLET;ORAL 085569-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Institutional CHLOROTHIAZIDE SODIUM chlorothiazide sodium INJECTABLE;INJECTION 202493-001 Jun 18, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Mylan CHLOROTHIAZIDE-RESERPINE chlorothiazide; reserpine TABLET;ORAL 087745-001 May 6, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
McKinsey
Merck
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.